SE360852B - - Google Patents

Info

Publication number
SE360852B
SE360852B SE06694/69A SE669469A SE360852B SE 360852 B SE360852 B SE 360852B SE 06694/69 A SE06694/69 A SE 06694/69A SE 669469 A SE669469 A SE 669469A SE 360852 B SE360852 B SE 360852B
Authority
SE
Sweden
Application number
SE06694/69A
Inventor
M Wilhelm
W Riess
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH728468A external-priority patent/CH507897A/de
Priority claimed from CH448069A external-priority patent/CH539602A/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of SE360852B publication Critical patent/SE360852B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE06694/69A 1968-05-16 1969-05-12 SE360852B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH728468A CH507897A (de) 1968-05-16 1968-05-16 Verfahren zur Herstellung von N-substituierten 9-(Aminoalkyl)-9,10-dihydro-9,10-äthano-anthrazenen
CH448069A CH539602A (de) 1969-03-25 1969-03-25 Verfahren zur Herstellung von neuen N-substituierten 9-(Aminoalkyl)-9,10-dihydro-9,10-äthano-anthrazenen

Publications (1)

Publication Number Publication Date
SE360852B true SE360852B (zh) 1973-10-08

Family

ID=25695575

Family Applications (1)

Application Number Title Priority Date Filing Date
SE06694/69A SE360852B (zh) 1968-05-16 1969-05-12

Country Status (13)

Country Link
US (2) US3778467A (zh)
JP (3) JPS4931982B1 (zh)
AT (6) AT304488B (zh)
BE (1) BE733092A (zh)
CA (1) CA927383A (zh)
DE (1) DE1923195A1 (zh)
ES (5) ES367292A1 (zh)
FR (1) FR2009896A1 (zh)
GB (1) GB1266889A (zh)
HU (1) HU162752B (zh)
NL (1) NL6907455A (zh)
SE (1) SE360852B (zh)
SU (3) SU404227A3 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS527972A (en) * 1975-07-07 1977-01-21 Sumitomo Chem Co Ltd Process for preparing novel morpholine derivatives
US5512575A (en) * 1991-08-15 1996-04-30 Zeneca Limited Methanoanthraceneyl methyl piperidinyl compounds
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
GB9216297D0 (en) * 1991-08-15 1992-09-16 Ici Plc Therapeutic agents

Also Published As

Publication number Publication date
ES388316A1 (es) 1973-12-16
DE1923195A1 (de) 1969-11-27
NL6907455A (zh) 1969-11-18
AT304487B (de) 1973-01-10
JPS4931982B1 (zh) 1974-08-27
AT304489B (de) 1973-01-10
ES388315A1 (es) 1973-12-16
BE733092A (zh) 1969-11-14
SU414786A3 (zh) 1974-02-05
US3778467A (en) 1973-12-11
AT304486B (de) 1973-01-10
AT304507B (de) 1973-01-10
SU407442A3 (zh) 1973-11-21
FR2009896B1 (zh) 1974-04-12
CA927383A (en) 1973-05-29
US3821214A (en) 1974-06-28
JPS4921132B1 (zh) 1974-05-30
HU162752B (zh) 1973-04-28
ES367292A1 (es) 1971-05-01
AT303019B (de) 1972-10-15
GB1266889A (zh) 1972-03-15
SU404227A3 (zh) 1973-10-26
ES388313A1 (es) 1973-12-16
AT304488B (de) 1973-01-10
ES388317A1 (es) 1973-12-16
FR2009896A1 (fr) 1970-02-13
JPS4813543B1 (zh) 1973-04-27

Similar Documents

Publication Publication Date Title
AU5506869A (zh)
AU5184069A (zh)
AU6168869A (zh)
SU404227A3 (zh)
AU6171569A (zh)
AU416157B2 (zh)
AU4811568A (zh)
AU4744468A (zh)
AU479894A (zh)
AU4224469A (zh)
BE727739A (zh)
BE709319A (zh)
BE728058A (zh)
AU5758767A (zh)
BE581157A (zh)
BE630165A (zh)
BE727399A (zh)
BE727154A (zh)
BE726864A (zh)
BE709320A (zh)
BE726397A (zh)
BE726312A (zh)
AU479393A (zh)
BE717170A (zh)
BE716454A (zh)